A 16-year-old boy presented with a 5-year history of progressive cognitive decline and behavioral change followed by generalized tonic-clonic and myoclonic seizures refractory to many anticonvulsants (valproic acid, phenobarbital, clonazepam, and topiramate) and cerebellar ataxia a year later. The son of consanguineous parents, he had a family history of 2 cousins who both had epilepsy and died at the ages of 15 and 25 years. Laboratory screening tests, including lactic acid, fundus examination, brain neuroimaging, and CSF, were normal. Skin biopsy (figure) revealed periodic acid-Schiff-positive intracellular polyglucosan inclusion bodies in myoepithelial and sweat gland duct cells.
The Mystery Case series was initiated by the Neurology ® Resident & Fellow Section to develop the clinical reasoning skills of trainees. Residency programs, medical student preceptors, and individuals were invited to use this Mystery Case as an educational tool. Responses were solicited through a group e-mail sent to the American Academy of Neurology Consortium of Neurology Residents and Fellows and through social media. All of the respondents correctly identified the Lafora bodies in the figure and concluded that the underlying diagnosis is Lafora disease. Eighty percentage of respondents accurately stated that this is an autosomal recessive disease associated with mutations in the EPM2A and EPM2B genes.
This case illustrates the value of a detailed family history in guiding the appropriate diagnostic tests for rare genetic disorders such as the progressive myoclonic epilepsies.
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